Skip to content

The effect of pudendal nerve block on bladder-related complications after transurethral prostatectomy

The effect of pudendal nerve block on bladder-related complications after transurethral prostatectomy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058372
Enrollment
Unknown
Registered
2022-04-07
Start date
2022-04-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter related bladder discomfort bladder spasm

Interventions

Pudendal nerve block group:Pudendal nerve block at the level of the pudendal canal

Sponsors

Jiaxing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. 120 cases of patients or their families who signed an informed consent form and volunteered to participate in this study and planned to undergo selective transurethral prostatectomy under general anesthesia; 2. American Association of Anesthesiologists (ASA) Grade II~III; 3.BMI18-30kg/m2.

Exclusion criteria

Exclusion criteria: 1. Patients with prostate cancer; 2. Patients with diabetes; 3. Severe urinary tract infection; 4. Neurogenic bladder dysfunction; 5. Patients who have recently been treated with M receptor blockers; 6. Patients with mental illness or language disorder; 7. Patients with detrusor weakness indicated by preoperative urodynamics; 8. The bladder fistula has been installed before the operation; 9. Those with urethral stricture, prostate cancer and other organic bladder outlet obstruction not caused by BPH; 10. Patients with lower urinary tract stones; 11. Those who have undergone prostate or bladder neck surgery; 12. The person known to be allergic to ropivacaine or any other anesthetic has infection at the puncture site; 13. Complicated with severe cardiovascular disease.

Design outcomes

Primary

MeasureTime frame
Incidence of catheter-related bladder discomfort and bladder spasm;

Secondary

MeasureTime frame
pain visual analogue scale;4-point scale to assess the severity of CRBD within 72 hours;Postoperative rescue analgesia dosage;

Countries

China

Contacts

Public ContactShenxu

Jiaxing First Hospital

fishsx0321@sina.com+86 13957306365

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026